2-((2,5-Dioxopyrrolidin-1-yl)oxy)-1,3-dimethyl-3,4,5,6-tetrahydropyrimidin-1-ium tetrafluoroborate, 97%, 10g

DIATRIZOIC ACID, 95%, 5g

2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-yl 4-methylbenzenesulfonate, 98%, 250mg

Benzo[b]thiophene-5-carbaldehyde, 95.0%, 100mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 60, 500 ml, 90 mm, 1 Piece

3-Fluoro-5-hydroxy-1,4-dihydropyridin-4-one, 95.0%, 1g

2-tert-Butyl-5-methyl-2H-pyrazol-3-yl amine, 97.0%, 1g

4-Fluoro-N-methoxy-N-methylbenzamide, 95.0%, 25g

5-Methyl-7-oxo-4,7-dihydro-pyrazolo[1,5- a ]pyrimidine-3-carboxylic acid, 95.0%, 1g

4-[(4-bromophenyl)methyl]morpholine, 95.0%, 10g

3-Amino-1,2,4-triazine, 97.0%, 10g

(1R,2S,5R)-2-Isopropyl-5-methylcyclohexanol, 99.0%, 25g

5-Chloronicotinonitrile, 98.0%, 5g